Accueil/Actions/QLGN

QLGN

USD

Qualigen Therapeutics Inc. Common Stock

$2.520-0.290 (-10.320%)

Prix en Temps Réel

Healthcare

Biotechnologie

États-Unis

Graphique des Prix

Loading Chart...

Métriques Clés

Métriques de Marché

Fondamentaux de l'Entreprise

Statistiques de Trading

Métriques de Marché

Ouverture

$2.810

Haut

$2.810

Bas

$2.495

Volume

0.10M

Fondamentaux de l'Entreprise

Capitalisation Boursière

5.1M

Industrie

Biotechnologie

Pays

United States

Statistiques de Trading

Volume Moyen

2.63M

Bourse

NCM

Devise

USD

Intervalle sur 52 Semaines

Bas $1.61Actuel $2.520Haut $8.81

Actualités Connexes

28 oct. 2025 · 03:57

GlobeNewswire

Qualigen Therapeutics to Rebrand as AIxCrypto After Stockholder Meeting on November 12, with Three Core Goals for 2025

Dubai, UAE / Beijing, China, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Qualigen Therapeutics Inc. (NASDAQ:QLGN) ("Qualigen", "QLGN" or the "Company"), a publicly-traded technology company majority owned by Faraday Future

Qualigen Therapeutics to Rebrand as AIxCrypto After Stockholder Meeting on November 12, with Three Core Goals for 2025

13 oct. 2025 · 01:00

GlobeNewswire

Qualigen Therapeutics Announces the Official Launch of C10 Cryptocurrency Asset Treasury (DAT) Purchases: Why Is This Pullback the Golden Moment CXC10 Has Been Waiting For?

Carlsbad, CA, Oct. 12, 2025 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (NASDAQ:QLGN) (the "Company") today announced the official launch of C10 Cryptocurrency Asset Treasury (DAT) purchases: Why is this pullback